Status:
COMPLETED
Clinical Trial to Evaluate ANT-1401 in Crow's Feet
Lead Sponsor:
Anterios Inc.
Conditions:
Lateral Canthal Lines
Crows Feet
Eligibility:
All Genders
30-60 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to confirm the effect of ANT-1401 in the treatment of Lateral Canthal Lines.
Eligibility Criteria
Inclusion
- 30 - 60 years of age
- mild to moderate Crow's Feet wrinkles (IGA 1-2) at rest
- moderate to severe Crow's Feet (IGA 2-3) on contraction
- moderate to severe Crow's Feet (SSA 2-3) on contraction
- Have adequate vision to assess facial wrinkles in a mirror
Exclusion
- botulinum toxin treatment in the prior 6 months
- history of periocular surgery, brow lift or related procedures
- soft tissue augmentation in the lateral canthal region in the prior 12 months
- dermabrasion or laser treatment in the periocular region in the last 6 months
- topical prescription-strength retinoids in the prior 3 months
- present or history of neuromuscular disease
- present or history of "dry eye"
- systemic aminoglycoside use in the week prior to treatment application
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT01809964
Start Date
March 1 2013
End Date
October 1 2013
Last Update
January 10 2014
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States, 35205
2
Miami, Florida, United States, 33137
3
Pinellas Park, Florida, United States, 33781
4
West Palm Beach, Florida, United States, 33401